Guidelines International Network | Guidelines International Network (GIN)

Pancreatic cancer. National consensus-based nutrition guideline

MeSH Terms: Biochemical Phenomena; Metabolism; and Nutrition (G06); Cancer / Neoplasms (C04); Digestive System Disorders / Diseases (C06); Endocrine System Diseases (C19); Therapeutics (E02); Nutrition (G06.696); Endocrine Gland Neoplasms (C04.588.322); Gastrointestinal Neoplasms (C04.588.274.476); Pancreatic Diseases (C06.689); Nutritional Support (E02.642.500); Pancreatic Neoplasms (C04.588.322.421)
Guideline Contact: Mirte Tilma ([email protected])
English Title Translation: Pancreatic cancer nutrition
Publication Scope: management
Countries of Application: Netherlands
Guideline Publication Status: Published
Languages: English
Authors: IKNL (NL)
Publication Year: 2012

MeSH Terms: Genetic Testing (N02.421.308.430); Pancreatic Neoplasms (C04.588.322.475)
Guideline Contact: [email protected]
Publication Date: 20-Nov-18
Publication Scope: management; screening
Countries of Application: United States
Guideline Publication Status: Published
Languages: English
Authors: ASCO (US)
Publication Year: 2018

MeSH Terms: Positron-Emission Tomography (E01.370.350.600.350.800.399); Pancreatic Neoplasms (C04.588.274.761)
Guideline Contact: Cindy Walker-Dilks ([email protected])
Publication Scope: assessment; management
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: McMaster University (CA)
Publication Year: 2009

MeSH Terms: pancreatic neoplasms, carcinoma, pancreatic ductal, pancreatic ductal adenocarcinoma, pancreatic cancer, pancreas cancer, pancreas adenocarcinoma, adjuvant treatment, cancer adjuvant therapy, adjuvant therapy, resected pancreatic ductal adenocarcinoma, chemotherapy, adjuvant, antineoplastic agents, drug therapy, pancreas adenocarcinoma, pancreas carcinoma, pancreas tumor, adjuvant chemotherapy, adjuvant chemoradiotherapy
Guideline Contact: Roxanne Cosby; [email protected]
Keywords: pancreatic ductal adenocarcinoma, pancreatic cancer, adjuvant treatment, antineoplastic agents, adjuvant chemoradiotherapy
Date for Review: In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date: 2022-06-20
Date of Last Evidence Search: 2021-11-25
Methods Applied: Systematic review-based, Externally reviewed, Evidence quality assessment, Patient/survivors/caregivers participation
Publication Scope: Guidelines; treatment
Countries of Application: Canada
Guideline Publication Status: Published
Languages: English
Authors: PEBC (Program in evidenced-based care)
Publication Year: 2022

MeSH Terms: Gastrointestinal Neoplasms (C04.588.274.476); Cancer / Neoplasms (C04); Pancreatic Diseases (C06.689)
English Title Translation: familial hereditary pancreatic carcinoma
Publication Scope: assessment; prognosis; screening
Countries of Application: Netherlands
Guideline Publication Status: Published
Languages: Dutch
Authors: IKNL (NL)
Publication Year: 2010

MeSH Terms: Gastrointestinal Neoplasms (C04.588.274.476); Pancreatic Neoplasms (C04.588.322.421); Pancreatic Diseases (C06.689)
English Title Translation: Pancreatic Cancer
Publication Scope: assessment; management
Countries of Application: Netherlands
Guideline Publication Status: Published
Languages: Dutch
Authors: IKNL (NL)
Publication Year: 2011